Focused ultrasound for glioblastoma (GBM): Clinical results and follow-on trial in Taiwan

Results from a pilot clinical trial evaluating the safety and feasibility of repeated focused ultrasound-induced blood–brain barrier (BBB) opening combined with the monoclonal antibody drug Avastin (bevacizumab) in patients with recurrent…

Continue Reading

News Source: medicalxpress.com